“The ‘A-‘ rating reflects our view of BMHC’s reduced operating losses, solid and competitive market share in a fairly large service area, strategic initiatives that could help increase revenue and further improve operations and acceptable pro forma unrestricted reserves,” said S&P analyst Suzie Desai.
The outlook is negative, reflecting S&P’s view of BMHC’s continued operating losses through interim 2016 that aren’t indicative of a credit in the “A” category.
More articles on healthcare finance:
5 study findings on health spending related to opioid addiction treatment
Cayman hospital system OKs large debt write-off
UnitedHealth’s Optum takes over Quest Diagnostics’ billing processes
